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Poly(A)-binding protein (PABP) stimulates translation initiation by binding simultaneously to themRNA poly(A)
tail and eukaryotic translation initiation factor 4G (eIF4G). PABP activity is regulated by PABP-interacting (Paip)
proteins. Paip1 binds PABP and stimulates translation by an unknown mechanism. Here, we describe the inter-
action between Paip1 and eIF3, which is direct, RNA independent, and mediated via the eIF3g (p44) subunit.
Stimulation of translation by Paip1 in vivo was decreased upon deletion of the N-terminal sequence containing the
eIF3-binding domain and upon silencing of PABP or several eIF3 subunits. We also show the formation of ternary
complexes composed of Paip1-PABP-eIF4G and Paip1-eIF3-eIF4G. Taken together, these data demonstrate that the
eIF3-Paip1 interaction promotes translation. We propose that eIF3-Paip1 stabilizes the interaction between PABP
and eIF4G, which brings about the circularization of the mRNA.
Translational control is an important mechanism by which
cells govern gene expression, providing a rapid response to
growth and proliferation stimuli, stress, and nutrient availabil-
ity (17, 18, 22). Initiation, the rate-limiting step of translation,
is an important target of translational control. Initiation entails
the recruitment of ribosomes to the mRNA, their traversing
the 5 untranslated region, and recognition of the initiation
codon. Ribosome recruitment is mediated by eukaryotic trans-
lation initiation factors (eIFs). All nuclear-transcribed eukary-
otic mRNAs possess a 5 cap structure (m7GpppN, where N is
any nucleotide and m is a methyl group), and most possess a 3
poly(A) tail. The 5 cap and the 3 poly(A) tail synergistically
enhance translation (25). The cap is bound by the eIF4F com-
plex, which consists of eIF4E, eIF4A, and eIF4G. eIF4E binds
directly to the mRNA 5 cap; eIF4A is an RNA helicase; and
eIF4G is a modular scaffolding protein that binds eIF4E,
eIF4A, eIF3, and the poly(A)-binding protein (PABP). Mam-
malian eIF3, the largest initiation factor, is composed of 13
different subunits that are named eIF3a through eIF3m and
range in mass from 170 to 25 kDa (8). While the individual
functions of the different subunits are not yet well established,
eIF3 plays an essential role in translation initiation by inter-
acting with the 40S ribosomal subunit and by promoting the
formation of the 43S preinitiation complex (21). Thus, eIF3
serves as a bridge between the mRNA-eIF4F complex and the
ribosome (18).
The poly(A) tail is bound by several molecules of PABP, an
essential protein that mediates the stimulatory effect of the
poly(A) tail on translation initiation (25, 41). PABP is a mul-
tidomain protein containing four phylogenetically conserved
RNA recognition motifs (RRMs) (1, 42). The C-terminal one-
third of the protein (PABC) contains a docking site for several
proteins (12, 29, 32, 40). We identified three partners of PABP,
termed PABP-interacting proteins (Paips): Paip1 (10), Paip2A
(29), and Paip2B (6). Paips bind to PABP via two distinct
PABP-binding motifs (PAMs) (40) (Fig. 1A). PAM1 is an
acidic region of approximately 25 amino acids that binds to
RRM2 in the N terminus of PABP, while PAM2 is a well-
defined and conserved region of approximately 15 amino acids
that binds to the PABC of PABP (27, 32, 40). The PAM2 motif
was subsequently identified in many proteins exhibiting diverse
functions (2), suggesting that PAM2 may play a role in protein-
protein interactions in a wide range of cellular processes.
Paip1 was discovered as a PABP-binding protein that stim-
ulates translation of luciferase reporter mRNA in COS-7 cells
(10). Paip1 possesses 39% similarity to the middle domain of
eIF4G (10), spanning amino acids 616 to 1087 (9). In eIF4G,
this region contains one of the two eIF4A binding sites and the
eIF3 binding site (24, 37). Consistent with this homology,
eIF4A coimmunoprecipitates with Paip1 (10). The mechanism
by which Paip1 stimulates translation has not been previously
elucidated. Here, we present evidence for an interaction be-
tween Paip1 and eIF3 and demonstrate that this interaction is
important for the translational stimulatory activity of Paip1.
MATERIALS AND METHODS
Reagents. Anti-Paip1 antibody was generated by immunizing rabbits with
recombinant GST-Paip1 p65. Goat anti-human eIF3 antiserum was a kind gift
from J. W. B. Hershey (University of California, Davis, CA) (3). Anti-eIF3g
antibody was received from T. K. Tang (Academia Sinica, Taipei, Taiwan) (23).
Anti-eIF3b and anti-eIF3e antibodies were from Santa Cruz Biotechnology.
Anti-PABP, anti--tubulin, and anti-eIF4E antibodies were from Cell Signaling
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Technology. Anti--actin antibody was from Sigma-Aldrich. Anti-eIF3c, anti-
eIF3f, and anti-eIF3k antibodies have been previously described (35). Anti-
Paip2A antibody has been previously described (45). Recombinant full-length
and truncated glutathione S-transferase (GST), GST-Paip1, GST-PABP, PABP,
and eIF4GI were prepared as previously described (24, 37, 40). A similar pro-
tocol was applied for the production of GST-tagged eIF3b, eIF3e, eIF3f, eIF3g,
and eIF3h. Purified rabbit reticulocyte eIF3 was a kind gift from W. C. Merrick
(Case Western Reserve University, Cleveland, OH) and was purified as de-
scribed previously (20), followed by gradient elution (100 to 450 mM KCl) from
phosphocellulose.
Cell culture and transfection. HeLa S3 cells were obtained from the American
Tissue Culture Collection (CLL-2.2) and maintained in Dulbecco’s minimum
essential medium (Sigma) containing 10% fetal bovine serum and 5 U/ml
penicillin-streptomycin solution (Gibco) in 5% CO2. DNA transfection was
performed using Lipofectamine Plus reagent (Invitrogen) following the manu-
facturer’s protocol.
siRNA transfection. All small interfering RNA (siRNA) duplexes were de-
signed as 21-mers and were purchased from Dharmacon. The sequences of the
siRNAs are as follows: siPaip1#1, 5-CAUGUCGGACGGUUUCGAUdTdT-3
(where dT is deoxyribosylthymine); siPaip1#2, 5-GCUGCAAAAGGGGAUG
AAGdTdT-3; sieIF3a, 5-GUCAACAGGUGAACAUAAAdTdT-3; sieIF3b,
5-GAGAGAAGGCGCACCAUGAdTdT-3; sieIF3e, 5-GGAUGCUCUUUG
ACUACCUdTdT-3; sieIF3g, 5-CCAUCCGUGUCACCAACUUdTdT-3;
sieIF4GI, 5-AACGUUACGACCGUGAGUUdTdT-3. siPABP and siPaip2A
were previously described (45). siRNA 4E-T inverted (15) was used as a control.
siRNA transfections were performed in six-well plates, 1 day before plasmid
transfection, as described previously (45).
Plasmid construction. Constructs encoding GST-HMK-Paip1 (where HMK is
heart muscle kinase) p65 and fragments thereof were described previously (40).
pcDNA3 encoding Flag-tagged Paip1 p65 isoform was also previously described
(29). The p51 and p45 isoforms of Paip1 were amplified by reverse transcription-
PCR (RT-PCR) using total RNA from HeLa cells. BamHI and XhoI sites were
added to the 5 and 3 ends, respectively. Plasmids encoding GST-HMK-Paip1
fragments were digested with BamHI and XhoI and subcloned using the same
restriction sites into pcDNA3-Flag-Paip1 as well as p51 and p45 isoforms of
Paip1. Human Paip1 p65 isoform was subcloned using the same sites in pcDNA3
containing a hemagglutinin (HA) tag to create the pcDNA3-HA-Paip1.
Human eIF3b cDNA was amplified by PCR from pcDNA3-HA-eIF3b ob-
tained from J. W. B. Hershey (University of California, Davis, CA). EcoRI and
XhoI sites were added to the 5 and 3 ends, respectively. PCR fragments were
inserted in pGEX-6P-1 (Pharmacia Biotech) to create GST-tagged eIF3b. Hu-
man eIF3e, eIF3f, eIF3g, and eIF3h cDNAs (35) were PCR amplified and
subcloned using EcoRI sites into pGEX-4T-1. The resulting plasmids were used
to produce recombinant GST-tagged eIF3e, eIF3f, eIF3g, and eIF3h proteins,
respectively.
The Tet-off promoter fragment was amplified by PCR from the pUHD 10-3
plasmid (19). SpeI and HindIII sites were added to the 5 and 3 ends, respec-
tively. The initial cytomegalovirus promoter from the pcDNA3-HA-Paip1 con-
struct was replaced by the Tet-off promoter, using SpeI and HindIII sites, to
create the inducible Tet-off HA-tagged Paip1 plasmid (pTet-HA-Paip1). Paip1
isoforms and fragments were subcloned into the pTet-HA-Paip1 using BamHI
and XhoI restrictions sites as described for pcDNA3-Flag-Paip1.
The full-length eIF4GI cDNA clone DKFZp762O191Q3 (pSP4GI) (9) was a
kind gift from Richard E. Lloyd (Baylor College of Medicine, Houston, TX). The
HA-tagged full-length eIF4GI fragment consisting of residues 1 to 1599 was
amplified from pSP4GI by PCR, digested with HindIII and XhoI, and inserted
into the pcDNA3 vector [pcDNA3-HA-eIF4GI(1–1599)]. The cDNA encoding
the N-terminal fragment of eIF4GI (eIF4GI N; amino acids 84 to 653) was
amplified from pcDNA3-HA-eIF4GI(1–1599) and cloned in pGEX-6P-1 (Phar-
macia Biotech) to generate pGEX-eIF4GI(84–653). The middle and C-terminal
fragments of recombinant eIF4GI (eIF4GI MC; amino acids 653 to 1600) have
been described previously (amino acids 457 to 1404, in reference 24; amino acids
613 to 1560, in reference 37).
RNA extraction and RT-PCR. Total RNA was extracted from HeLa cells using
Trizol reagent (Invitrogen) according to manufacturer’s instructions. Reverse
transcription (RT) was performed using Superscript II (Invitrogen), oligo(dT)
and 1 microgram of total RNA, according to the manufacturer’s instructions.
FIG. 1. (A) Structural organization and interactions of PABP with Paip proteins. (B) Structural organization of the human Paip1 gene,
mRNAs, and proteins. The p51 isoform is generated by alternative splicing of exon 1B and lacks amino acids 10 to 88. The p45 isoform is generated
from a downstream AUG present in exon 2. Primers a, b, and c used for RT-PCR are indicated. (C) HeLa cells were treated with siRNA against
Paip1 exon 1B. Total RNA was extracted, and RT-PCR experiments were performed with primers a and b for mRNA encoding p65 and p51
isoforms of Paip1 (lanes 1 and 2) and with primers c and b for mRNA encoding p45 isoform (lanes 3 and 4). Size marker and PCR products for
the p65 (670 bp), the p51 (430 bp), and the p45 (220 bp) isoforms are indicated. (D) HeLa cells were treated with siRNA against exon 1B (lane
2, siRNA#1) or exon 5 (lane 3, siRNA#2) of the Paip1 gene or with control siRNA (Ctrl.) (left panel). HeLa cells were transfected with pCDNA3
Flag-tagged constructs expressing the p65, p51, or p45 isoform of Paip1 or left nontransfected (Nt.) (right panel). Extracts were subjected to
SDS-PAGE and Western blotting (WB) using the indicated antibodies. Positions of molecular weight markers are indicated on the right.
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One microliter of RT template was incubated with specific primers and PWO
polymerase (Roche) according to the supplier’s instruction.
Quantitative RT-PCR. Total RNA was treated with a Turbo DNA-free kit
(Ambion) prior to RT. RT reactions were diluted in 80 l of water, and 1 l was
used for each reaction of quantitative PCR. PCRs were performed in duplicate,
in a total reaction volume of 10 l in 96-well reaction plates. PCRs were carried
out in a Mastercycler Realplex2 (Eppendorf) using iQ Sybr Green Supermix
(Bio-Rad) according to the manufacturer’s instructions. The amplification con-
ditions consisted of an initial denaturation step of 2 min at 94°C followed by 40
cycles of 15 s at 94°C, 15 s at 55°C, and 30 s at 68°C. Renilla mRNA was quantified
and normalized against -actin mRNA. The CT method (where CT is thresh-
old cycle) was used to determine the relative variation of Renilla mRNA between
experimental samples, using the repressed expression with tetracycline (Tet) as
a reference. Results are presented as the luciferase mRNA ratio between the
induced condition (no Tet) and the repressed condition (with Tet).
Primer sequences. The primers used for cloning were as follows (restriction
sites are underlined): for Paip1, 5-TCAGGATCCGCTAAGCCCCAGGTGGT
T-3 (p45 sense), 5-GGCTCGAGTTACTGTTTTCGCTTACG-3 (Paip1 anti-
sense), and as previously described (40); Tet-off promoter, 5-ATTGACTAGT
TGCATGCTCGAGTTTACCA-3 (sense) and 5-TGGAAGCTTATCGATGC
GGCCGCGCTAGCA-3 (antisense); eIF4GI(84-653), 5-ATGCGGATCCCA
AGTAATGATGATCCC-3 (sense) and 5-ATGCCTCGAGTTAATCCAGTG
GCCGCAGTGGTGTTTT-3 (antisense); eIF3b, 5-CAGAATTCCAGGACG
CGGAGAACGTGGC-3 (sense) and 5-TTCTCGAGTCACTCCTGATTCCC
GAGGG-3 (antisense). The primers used for RT-PCR were as follows: p65/p51
sense (primer a), 5-GGAGAACTGGAAAGCCGAGGGTA-3; p65/p51/p45
antisense (primer b), 5-GTGTAACTGGAAGAATAACCTGAAGGG-3; and
p45 sense (primer c), 5-ACGTCTCTCCTGAGAACTACCGAGT-3. The primers
used for the quantitative PCR were 5-CAGTGGTGGGCCAGATGTAAAC
AA-3 (sense) and 5-TAATACACCGCGCTACTGGCTCAA-3 (antisense) for
Renilla; -actin sense and antisense primers were previously described (33).
GST pull-downs. HeLa cells were grown to 80% confluence and collected in
buffer A (20 mM HEPES-KOH, pH 7.4, 100 mM KCl, 0.1% NP-40, 0.5 mM
EDTA, 10% glycerol, 25 mM -glycerophosphate, 2 mM Na3VO4, 0.5 mM NaF,
10 g/ml aprotinin, 10 g/ml leupeptin, 5 g/ml pepstatin A, 0.5 mM phen-
ylmethylsulfonyl fluoride). Where indicated, extracts were subjected to
RNase treatment, as previously described (44). Recombinant GST-Paip1 or
GST alone (250 nM) was incubated with HeLa cell extract (5 mg of protein/
ml) in the presence of glutathione-Sepharose beads for 3 h at 4°C. Beads were
washed five times in buffer A, and bound proteins were eluted with sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) loading buffer
(50 mM Tris-HCl, pH 6.8, 2% SDS, 0.1% bromophenol blue, 10% glycerol, 10
mM dithiothreitol, 5% -mercaptoethanol). Eluates were subjected to SDS-
PAGE and Western blotting. For mass spectrometry analysis, eluted proteins
were separated by 4 to 15% SDS-PAGE. Bands which were present only in a
GST-Paip1 pull-down sample were excised from the gel, stored in 1% acetic acid,
and subjected to mass spectrometry analysis (Ge´nome Que´bec Innovation Cen-
tre, Montre´al, QC, Canada).
To perform GST pull-downs using purified proteins, recombinant GST-Paip1
or GST was incubated with recombinant PABP, recombinant eIF4GI, or purified
eIF3 (all at 100 nM), as indicated in Fig. 5, in buffer B (20 mM HEPES-KOH,
pH 7.4, 15 mM NaCl, 140 mM KCl, 0.5% NP-40, 2.5 mM MgCl2), supplemented
with 0.1 mg/ml bovine serum albumin, in the presence of glutathione-Sepharose
beads for 2 h at 4°C. For experiments using the recombinant GST-tagged eIF3
subunit, 40 ng of p51 Paip1 was incubated in 200 l of buffer B with 0.1 mg/ml
bovine serum albumin with 1 g of GST-eIF3b, -eIF3e, -eIF3f, -eIF3g, or -eIF3h
or GST alone. Beads were washed five times in buffer B, and bound proteins
were eluted with SDS-PAGE loading buffer. Eluates were subjected to SDS-
PAGE and Western blotting.
Immunoprecipitation. HeLa cell extracts (1 mg of protein/ml) were used for
immunoprecipitation, as previously described (34). The antibodies indicated in
Fig. 2C and 4C were added to the extract together with protein G-Sepharose
beads and incubated for 90 min at 4°C. Bound proteins were eluted with SDS-
PAGE loading buffer and subjected to SDS-PAGE and Western blotting.
Far-Western analysis. The procedure for far-Western analysis was previously
described in detail (28). Forty micrograms of purified rabbit reticulocyte eIF3
was resolved by 8% SDS-PAGE. 32P-labeled HMK-p45 Paip1 was used as a
probe at 250,000 cpm/ml of hybridization solution.
Translation assays. HeLa cells were seeded in six-well tissue culture dishes 1
day prior to transfection. Cells were cotransfected with 250 ng of pTet-HA-Paip1
or control vector, 250 ng of pUHD-15-1 which expresses the Tet-controlled
transactivator (tTA) (19), and 50 ng of pRL-CMV (Promega) per well as a
Renilla luciferase reporter construct. pBI-L vector (Stratagene) expressing firefly
luciferase was used as a control vector. Four hours after transfections, the
medium was replaced and supplemented with Tet at a final concentration of 0 or
300 ng/ml. Tet at 300 ng/ml caused a complete inhibition of the Tet-off promoter
(19). Consequently, this was used as the repressed condition, and medium with-
out Tet was used as the induced condition. Cells were harvested 48 h after
transfection and lysed using 400 l/well of 1 passive lysis buffer (Promega).
Four microliters of extract was used to quantify Renilla luciferase activity with a
Dual-Luciferase Reporter Assay system (Promega). Protein concentration was
determined using 4 l of HeLa extract and Bio-Rad protein assay reagent
according to the manufacturer’s instruction. Renilla luciferase activity was cor-
rected based on protein concentration. The relative induction for each construct
was determined by calculating the ratio of Renilla luciferase activity between the
induced condition (no Tet) and the repressed condition (300 ng/ml Tet). Extracts
were subjected to SDS-PAGE and Western blotting.
RESULTS
Paip1 exists in three different isoforms. Human Paip1 was
originally described as a 70-kDa protein (10). Subsequently,
two closely related cDNAs were entered into the GenBank
database. The related cDNAs have most probably arisen from
alternative splicing and promoter usage (see description below
and Fig. 1B). We developed an anti-Paip1 antibody that rec-
ognizes three different Paip1 isoforms at 65, 51 and 45 kDa
after resolution of a HeLa cell extract by SDS-PAGE (Fig. 1D,
lane 1). The full-length isoform (p65) corresponds to the orig-
inally described Paip1 (accession number NM_006451) (10),
while the p51 isoform lacks amino acids 10 to 88 due to alter-
native splicing within exon 1B (accession number NM_182789)
(Fig. 1B). The p45 isoform consists of amino acids 113 to 479
of the p65 isoform (Fig. 1B). The mRNA encoding the p45
isoform is produced from an upstream promoter and uses an
alternate first exon (Fig. 1B, exon 1A), resulting in a different
5 untranslated region and consequently the utilization of a
downstream in-frame AUG (accession number NM_183323).
The existence of the three different Paip1 mRNAs described in
the GenBank database was confirmed by RT-PCR (Fig. 1C,
lanes 2 and 4) and sequence analysis. To further correlate the
three cDNA database entries with the three isoforms of Paip1
proteins, HeLa cells were treated with two different siRNAs
against Paip1 mRNAs. The first siRNA targets exon 1B of the
mRNAs encoding the p65 and p51 isoforms while the second
targets exon 5, which is common to all three isoforms. The
second siRNA, which targets all three mRNAs, caused a dra-
matic reduction in the amount of all three protein isoforms
(Fig. 1D, lane 3). In contrast, the first siRNA, which targets
p65 and p51 mRNAs, dramatically reduced the expression of
only the p65 and p51 isoforms (Fig. 1D, lane 2). In addition,
mRNAs expressing p65 and p51 isoforms of Paip1 are no
longer detectable by RT-PCR in HeLa cells treated with the
first siRNA (Fig. 1C, lane 1), whereas the mRNA expressing
the Paip1 p45 isoform was amplified (Fig. 1C, lane 3).
Transfection of a DNA vector expressing an N-terminal
Flag-tagged Paip1 isoform (p65, p51, or p45) into HeLa cells
leads to the expected expression of a slightly higher-molecular-
weight protein (due to the presence of the Flag-tagged pep-
tide) than the corresponding Paip1 isoform (Fig. 1D, lanes 5 to
7). No increase in expression of the lower-molecular-weight
Paip1 p45 isoform was observed when Flag-tagged p65 or p51
Paip1 vector was transfected (Fig. 1D, lanes 5 and 6). There-
fore, the downstream in-frame AUG initiating p45 Paip1 trans-
lation is not used in p65 and p51 Paip1-encoding mRNAs.
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Taken together, these data demonstrate that the three iso-
forms of Paip1 are translated from three distinct mRNAs.
Paip1 interacts with eIF3. To understand how Paip1 stimu-
lates translation, we wished to identify Paip1-interacting pro-
teins. A GST pull-down assay was performed using a HeLa cell
extract, and binding partners of the GST-Paip1 p65 isoform
(referred to as GST-Paip1) were identified by mass spectrom-
etry. The p65 isoform was chosen because it was the only
isoform known at the time of the experiment to bind PABP
and to stimulate translation (10). GST-Paip1 specifically coe-
luted with several eIF3 subunits, together with PABP (Fig.
2A). The association of eIF3 with Paip1 was confirmed by
Western blotting using a goat anti-human eIF3 antiserum (Fig.
2B, upper panel) and antibodies against the eIF3f and eIF3k
subunits (Fig. 2B). Importantly, the Paip1-eIF3 interaction
also occurred in an RNase-treated cell extract, suggesting that
the binding of eIF3 to Paip1 is RNA independent (Fig. 2B).
eIF4E failed to coelute with GST-Paip1, further indicating that
the pull-down was not due to tethering through RNA (Fig.
2B). To confirm the eIF3-Paip1 interaction, eIF3 was immu-
noprecipitated from a HeLa cell extract using a goat anti-
human eIF3 antiserum. All three isoforms of Paip1 (p65, p51,
and p45) were coimmunoprecipitated with eIF3 (Fig. 2C, lane
4). PABP was found to be associated with eIF3 at very low
stoichiometry (much less than 2%) (Fig. 2C, lanes 2 and 4)
compared to Paip1 (more than 5%). The coimmunoprecipita-
tion specificity was confirmed by Western blotting using anti-
-tubulin and anti-goat immunoglobulin G (IgG) antibodies
(Fig. 2C). These results demonstrate that eIF3 binds to all Paip1
isoforms, independently of PABP. Furthermore, GST-Paip1 in-
teracted with purified rabbit reticulocyte eIF3 in a GST pull-down
assay as determined by Western blotting with eIF3b antibody
(Fig. 2D). Taken together, these data show that the interaction
between eIF3 and Paip1 is specific and RNA independent.
Paip1 binds directly to the g subunit of eIF3 (p44). To
determine whether the Paip1-eIF3 interaction is direct and
FIG. 2. RNA-independent interaction between Paip1 and eIF3. (A) GST pull-down experiments were conducted with GST-Paip1 or GST on
HeLa cell extracts. Eluates were subjected to SDS-PAGE. Bands unique to GST-Paip1 (circled) were excised and subjected to mass spectrometry
analysis. Identified proteins are indicated next to the analyzed bands. Protein sequence coverage is as follows: eIF3a, 15.4%; eIF3b, 14.4%; eIF3c,
20.2%; PABP, 56.0%; eIF3g, -h, and -i, 10%. (B) GST pull-downs were conducted with GST-Paip1 or GST in untreated or micrococcal
nuclease-treated HeLa cell extracts. Eluates were subjected to SDS-PAGE and Western blotting (WB) using the indicated antibodies. (C) Im-
munoprecipitation using anti-eIF3 antibody (eIF3) or preimmune goat serum (IgG) was conducted using a HeLa cell extract. Extract (Input) and
eluates (IP) were subjected to SDS-PAGE and Western blotting using the indicated antibodies. The Paip1 isoforms and IgG heavy chain (HC)
are indicated. (D) GST pull-downs were conducted with GST or GST-Paip1 together with purified eIF3. Eluates were subjected to SDS-PAGE
and Western blotting using the indicated antibodies.
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also to identify the eIF3 subunit that interacts with Paip1,
purified rabbit reticulocyte eIF3 was resolved by SDS-PAGE
and transferred onto a nitrocellulose membrane. Ponceau S
staining revealed the presence of 11 major bands correspond-
ing to the known eIF3 subunits (Fig. 3A, left panel) (note that
eIF3a is partially degraded as observed in many other reports)
(39). The membrane was used for far-Western analysis with
32P-labeled HMK-p45 Paip1 as a probe. One strong band at 72
kDa and two weaker bands around 55 kDa were detected by
autoradiography (Fig. 3A, middle panel). Ponceau S staining
did not reveal any major protein migrating around 72 kDa,
indicating that this Paip1-interacting protein has a very high
affinity for the 32P-labeled probe (Fig. 3A). Considering the
size of this protein and the strength of this interaction, it is
highly likely that PABP is the minor contaminating protein,
which is present at very low stoichiometry. The Paip1-PABP
interaction is extremely strong and has an apparent Kd of 1.9
nM (10, 40). Therefore, a duplicate membrane was used for
Western blotting with anti-PABP antibody, which demon-
strated the presence of residual PABP in the eIF3 preparation
(Fig. 3A, right panel). We estimate that there is 	0.1% of
PABP in the eIF3 preparation. Additional Western blotting
experiments also demonstrated a similar level of contamina-
tion of the purified eIF3 with Paip1 and eIF4GI (data not
shown). To identify the two weaker bands, duplicate mem-
branes were used for Western blotting with antibodies raised
against various eIF3 subunits. eIF3e, eIF3f, eIF3g, and eIF3h
are the only eIF3 subunits at the corresponding size of the
autoradiographic signal (7, 30, 39). Recombinant GST-tagged
eIF3e, eIF3f, eIF3g, and eIF3f were produced in E. coli, puri-
fied, and employed for GST pull-down experiments against
recombinant p51 Paip1. GST-eIF3b and GST were used as
negative controls. Paip1 interacted only with the GST-eIF3g
(Fig. 3B). A GST pull-down was performed using a HeLa cell
extract and the same GST-tagged proteins. Only GST-eIF3g
pulled down Paip1 from the cell extract (Fig. 3C). -Tubulin
was not associated with Paip1, demonstrating the specificity of
the interaction (Fig. 3C). Taken together, these results dem-
onstrate that Paip1 interacts directly with the g subunit (p44) of
eIF3. This interaction occurs in vitro and in vivo.
The eIF3-binding domain in Paip1 spans amino acids 116 to
143. To map the eIF3-binding domain in Paip1, GST-Paip1
pull-downs were performed using deletion mutants of Paip1
(Fig. 4A). eIF3 interacted only with fragments containing
amino acids 116 to 143 of Paip1 (Fig. 4B). The interaction was
observed with antibodies raised against several eIF3 subunits:
eIF3b, eIF3e, and eIF3g (Fig. 4B). Similarly, when Flag-tagged
Paip1 fragments were expressed in HeLa cells, only those con-
taining amino acids 116 to 143 copurified with eIF3 (Fig. 4C).
Simultaneous binding of Paip1 with eIF4G, PABP, and
eIF3. To gain insight into the functional significance of the
eIF3-Paip1 interaction, we examined whether eIF3, Paip1,
PABP, and eIF4G form complexes. GST pull-downs were con-
ducted using GST-Paip1 as bait in the presence of recombinant
PABP, eIF4GI proteins, and purified eIF3. Because it is diffi-
cult to produce intact full-length recombinant eIF4GI (24),
eIF4GI fragments were employed for these experiments: the
eIF4GI N fragment, which possesses PABP but not eIF3-bind-
ing activity (24), and the eIF4GI MC fragment, which pos-
sesses eIF3 but not PABP-binding activity (37). eIF4GI N was
pulled down by GST-Paip1 only when PABP was present (Fig.
5A), indicating that PABP interacts simultaneously with
eIF4GI and Paip1. Similarly, eIF4GI MC was pulled down by
GST-Paip1 only in the presence of eIF3, indicating that eIF3
interacts simultaneously with Paip1 and eIF4GI (Fig. 5B).
These results thus demonstrate that ternary complexes com-
posed of Paip1-PABP-eIF4G and Paip1-eIF3-eIF4G can form
in vitro.
Stimulation of translation by Paip1 isoforms and frag-
ments. To examine the effect of Paip1-eIF3 interaction on
Paip1 translational stimulatory activity, in vivo translation as-
says were performed. DNA vectors expressing different Paip1
isoforms and fragments (Fig. 6A), under the control of the
FIG. 3. Identification of Paip1-interacting subunit of eIF3. (A) Pu-
rified eIF3 was subjected to SDS-PAGE and transferred onto a nitro-
cellulose membrane. Membrane was subjected to Ponceau S staining
and far-Western blotting using 32P-labeled HMK-Paip1 p45 as a probe.
A duplicate membrane was subjected to Western blotting (WB) with
PABP antibody. eIF3 subunits and fragments of eIF3a are indicated.
(B) GST pull-downs were conducted on recombinant p51 Paip1 with
GST-eIF3b, GST-eIF3e, GST-eIF3f, GST-eIF3g, GST-eIF3h, or GST.
Eluates were subjected to SDS-PAGE and Western blotting (WB)
using Paip1 or GST antibodies. (C) GST pull-downs were conducted
with GST-eIF3b, GST-eIF3e, GST-eIF3f, GST-eIF3g, GST-eIF3h, or
GST on a HeLa cell extract. Eluates were subjected to SDS-PAGE and
Western blotting (WB) using the indicated antibodies.
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Tet-off promoter (19), were transfected into HeLa cells along
with constructs expressing the Renilla luciferase and the tTA.
Each construct yielded comparable amounts of protein (Fig.
6B). The Paip1 isoforms were expressed at levels about two- to
threefold higher than the endogenous protein (Fig. 6B). The
relative induction of luciferase activity mediated by Paip1 was
determined by calculating the ratio of Renilla luciferase activity
between induced (without Tet) and repressed (300 ng/ml Tet)
expression of HA-tagged Paip1. The p65 form of Paip1 en-
hanced translation by approximately 3.5-fold, as previously re-
ported (10), and the p51 isoform enhanced translation to the
same extent (Fig. 6C). Strikingly, the p45 isoform enhanced
translation approximately sevenfold (Fig. 6C). Overexpression
of Paip1 isoforms had no effect on Renilla mRNA levels (Fig.
6D). Thus, the p45 isoform of Paip1 is a more potent transla-
tional enhancer than the p65 or p51 isoform. The possible
reasons for these differences among the different Paip1 iso-
forms are addressed in the Discussion. To determine which
region of Paip1 is required for translational enhancement,
constructs expressing different Paip1 fragments were trans-
fected into HeLa cells. Paip1 consisting of residues 1 to 415,
lacking PAM1, failed to stimulate luciferase activity (Fig. 6C),
as previously reported (10), showing that binding of Paip1 to
PABP via this domain is required for Paip1 activity. Paip1 has
a higher affinity for the RRM1 to RRM4 of PABP (Kd of 0.56
nM) (40) than the PABC domain (Kd of 4.7 nM) (40), indi-
cating that the PAM1 domain binds more strongly to PABP
than the PAM2 domain (10). Paip1 consisting of residues 144
to 479, lacking the eIF3-binding domain, exhibited reduced
stimulatory activity (50% compared to p45). These data con-
firm the importance of PAM1, and thus PABP binding, to
Paip1 translational activity (10) and also demonstrate that the
eIF3-Paip1 interaction is required for maximal Paip1 activity in
translational enhancement.
Paip1 requires eIF3 and PABP to exert its full effect. To
confirm the importance of eIF3 and PABP for Paip1 activity,
the expression of PABP, as well as that of several eIF3 sub-
units, was silenced by siRNA, and the effect on Paip1 activity
was examined. Because p45 is the most translationally active
isoform of Paip1, it was employed in these experiments. Renilla
luciferase mRNA levels were not affected by siRNA treat-
ments (Fig. 7B). Similarly, we failed to observe any reduction
in HA-Paip1 p45 expression or induction (Fig. 7C and D),
which could have been responsible for the attenuation in the
stimulation of Renilla luciferase activity. Paip1 translational
FIG. 4. Identification of the eIF3-binding domain of Paip1.
(A) Schematic representation of Paip1 fragments used in GST pull-
downs and Flag immunoprecipitation. Relative binding was evaluated
visually. (B) GST pull-downs were conducted with the indicated GST-
Paip1 fragments in HeLa cell extracts. Eluates were subjected to SDS-
PAGE and Western blotting (WB) with the indicated antibodies. The
GST and GST-tagged p65 proteins are indicated. (C) HeLa cells were
transfected with plasmids expressing the indicated Flag-tagged Paip1
fragments or left untransfected (NT). Immunoprecipitations were per-
formed 48 h posttransfection. Eluates were subjected to SDS-PAGE
and Western blotting with the indicated antibodies.
FIG. 5. Simultaneous binding of Paip1, eIF3, PABP, and eIF4GI.
GST pull-downs were conducted with GST-Paip1 under the following
conditions: in the presence of eIF4GI N and PABP (A) and of eIF4G
MC and eIF3 (B). Eluates were subjected to SDS-PAGE and West-
ern blotting (WB) with the indicated antibodies. Blots were then
stained with Coomassie blue stain (CB).
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enhancement was reduced by PABP silencing (Fig. 7A)
whereas control vector expression was not affected and was
similar to untreated cells (data not shown and Fig. 6C). Since
PABP knockdown induces the proteasome-mediated degrada-
tion of Paip2A (45), we also silenced Paip2A (Fig. 7C), which
had no effect on Paip1 activity (Fig. 7A). Knockdown of
eIF4GI had no effect on Paip1 function (Fig. 7A and C),
probably due to the redundant function of eIF4GII, which is
also expressed in HeLa cells (43). The lack of effect in knock-
downs of Paip2A and eIF4GI indicates that the PABP knock-
down-mediated effect on Paip1 function is specific. These data
demonstrate that PABP is required for optimal Paip1 activity.
Paip1-dependent translation stimulation was decreased to
similar levels upon silencing of eIF3a, eIF3b, eIF3e, and eIF3g
(Fig. 7A). Renilla luciferase mRNA levels and HA-Paip1 p45
expression were not affected by the knockdown of eIF3 sub-
units (Fig. 7B and D). Silencing of eIF3b, eIF3e, and eIF3g
caused reduced levels of eIF3a (Fig. 7D) because silencing of
these subunits may alter the folding, function, or stability of
other eIF3 subunits including eIF3a (16, 35). Thus, destabili-
zation of eIF3 can potentially lead to the proteasome-mediated
degradation of eIF3a (4). eIF3 function requires core subunits,
without which eIF3 cannot be properly folded or function in
translation (35, 38). In mammalian cells and in Saccharomyces
cerevisiae, eIF3a is a core component (21, 35). In conclusion,
Paip1 requires eIF3 core subunits to exert its full activity.
DISCUSSION
Here, we provide evidence that Paip1 stimulates translation
by interacting with eIF3. The interaction is direct and RNA
independent and mediated by eIF3g (p44). Deletion of the
eIF3-binding domain in Paip1, as well as siRNA-mediated
silencing of eIF3 subunits, resulted in diminished Paip1-medi-
ated translational enhancement of a luciferase reporter in
HeLa cells. We therefore propose that the interaction of Paip1
with eIF3 stabilizes the circular mRNA conformation, which is
formed by the eIF4G-PABP interaction (Fig. 8). Consistent
with this model, simultaneous interactions between Paip1-
eIF3-eIF4GI and Paip1-PABP-eIF4GI were documented (Fig.
5). The identification of eIF3 as a Paip1 binding partner adds
to our earlier finding that Paip1 interacts with eIF4A (10) in
that, like eIF4G, Paip1 can interact with both eIF3 and eIF4A.
Paip1 possesses homology to the middle domain of eIF4GI
(amino acids 616 to 1087) (10), which contains binding sites for
eIF4A and eIF3 (24, 31, 37). Thus, Paip1 is expected to inter-
act with eIF3 and eIF4A. The binding domain for eIF3 in
Paip1 is contained within the eIF4G-homologous region (10)
(minimal proposed sequence, amino acids 712 to 742 in
eIF4GI), although the eIF3-binding domain in eIF4G is much
larger (amino acids 711 to 1128) (37); we note that a smaller
domain exhibiting weaker affinity, spanning amino acids 1014
to 1117, has also been reported (31). This suggests that Paip1
does not employ an eIF3-binding domain identical to that of
eIF4G. Indeed, the GST pull-down experiments using purified
proteins (Fig. 5B) showed that Paip1 and eIF4G can bind to
eIF3 simultaneously rather than competing for binding. Thus,
it is possible that Paip1-eIF3 binding might affect or be affected
by the eIF3-eIF4G interaction.
The eIF3-binding domain in Paip1 overlaps with a region
where one of the PABP-binding domains, PAM2, resides (40);
therefore, PABP and eIF3 can potentially compete for Paip1
binding via the PAM2 domain. However, PABP could remain
FIG. 6. Paip1-dependent translation stimulation in vivo. (A) Sche-
matic representation of HA-tagged Paip1 fragments expressed in HeLa
cells. (B) Cells were transfected with the indicated pTet-HA-Paip1 plas-
mids together with constructs expressing the Renilla luciferase and the
tTA. Cells were placed in medium containing 0 or 300 ng/ml of Tet.
Extracts were subjected to SDS-PAGE and Western blotting (WB) with
the indicated antibodies. (C) Renilla luciferase activity was quantified in
HeLa cell extracts from panel B and normalized on the total protein level.
Relative induction of the luciferase reporter was determined by calculat-
ing the ratio of Renilla luciferase activity between induced (without Tet)
and repressed (300 ng/ml Tet) expression of the indicated HA-tagged
Paip1. Error bars denote the standard error of the mean for three inde-
pendent experiments. (D) Renilla luciferase mRNA was measured by
quantitative RT-PCR from total RNA extracted from duplicate HeLa
cells from panel B. Total RNA was DNase-treated and reverse tran-
scribed. Using RT products, Renilla mRNA was quantified and normal-
ized against -actin mRNA. Luciferase mRNA ratio is calculated by the
CT method using the repressed expression (Tet) for each Paip1
construct as a reference. Error bars denote the standard error of the mean
for three independent experiments.
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associated with Paip1 through its PAM1 domain because the
Paip1 PAM1-PABP RRM interaction is much stronger (Kd of
0.56 nM) (10, 40) than the PAM2-PABC interaction (Kd of 4.7
nM) (40). This should favor the formation of the ternary com-
plex between PABP, Paip1, and eIF3 and therefore stabilize
the circular mRNA conformation together with eIF4G.
Paip1 interacts directly with eIF3g (p44) as determined by
GST pull-down (Fig. 3B). eIF3g/Tif35 is one of the core sub-
units in Saccharomyces cerevisiae (21, 38) and associates
strongly with the central part of mammalian eIF3 (11); how-
ever, it is not a core subunit of the reconstituted mammalian
eIF3 (35). eIF3g is not required for the stable interaction of the
40S ribosome-initiation factor complex with the mRNA at the
AUG codon (35), suggesting its involvement in translational
regulation. Human eIF3g interacts strongly with eIF3a and
more weakly with eIF3b and eIF3c (7). A recent mass spec-
trometry report also supports these interactions by showing
that human eIF3g is part of a stable eIF3 subcomplex com-
posed of eIF3a, eIF3b, eIF3g, eIF3i, and eIF3c, which also
exists in yeast eIF3 (46). eIF3g is phosphorylated on Thr41 and
Ser42 (5, 11, 36), and this phosphorylation is increased by
about threefold upon serum stimulation (11). As recently sug-
gested, phosphorylation of eIF3 subunits could stabilize eIF3
complex (46) and consequently favor peripheral interactions.
This raises the possibility that phosphorylation of eIF3g might
stimulate the interaction between Paip1 and eIF3. The physi-
ological conditions under which the Paip1-eIF3 interaction is
modulated remain to be studied.
The far-Western analysis demonstrated a visually weak in-
teraction between eIF3 subunits and Paip1 compared to the
FIG. 7. Effect of eIF3 and PABP on Paip1-dependent translation stimulation in vivo. (A) HeLa cells were transfected with the indicated siRNAs, and siRNA
4E-T inverted (15) was used as a control (Ctrl). At 24 h after siRNA transfection, cells were transfected as described in the legend of Fig. 6B using the
pTet-HA-Paip1 p45 construct. Cells were placed in medium containing 0 or 300 ng/ml of Tet. Data are expressed as the percentage of the relative increase in
induction in cells transfected with control siRNA (set at 100%). Error bars denote the standard error of the mean of three independent experiments. (B)Renilla
luciferase mRNA was measured by quantitative RT-PCR from total RNA extracted from duplicate HeLa cells from panel A. Total RNA was DNase treated
and reverse transcribed. By using RT reactions, Renilla mRNA was quantified and normalized against -actin mRNA. The luciferase mRNA ratio is calculated
by the CT method using the repressed expression ( Tet) for each siRNA as a reference. Error bars denote the standard error of the mean for three
independent experiments. (C and D) Extracts from panel A were subjected to SDS-PAGE and Western blotting (WB) with the indicated antibodies.
FIG. 8. Model for the mechanism of Paip1-mediated translation
stimulation. Paip1 stabilizes the interaction between eIF4G and PABP
by binding to eIF3, which in turn binds to eIF4G and the 40S ribosome
(not shown in the figure). m7G, cap structure.
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PABP-Paip1 interaction (Fig. 3A). However, the proper re-
folding of proteins on the membrane is a crucial element for
protein-protein interaction, but it is not always efficient (13,
14). The lack of proper refolding might be an explanation of
why we failed to observe a stronger signal in the far-Western
experiment. The best folding for eIF3g might be achieved only
when it is incorporated into eIF3. It is also possible that the
eIF3-Paip1 interaction occurs through several subunits.
In the in vivo luciferase reporter translation assays, the p45
isoform was more active than p65 or p51 (approximately two-
fold) (Fig. 6C). Because of the N-terminal location of the eIF3
binding site on the p45 isoform (Fig. 1B), it is possible that the
PAM2 domain is more accessible, and, thus, its binding to eIF3
is increased. Indeed, many PAM2-containing proteins possess
the PAM motif near the N or C terminus (2). Paip1 isoforms
are differentially expressed (Fig. 1D), which renders difficult
any direct comparison of affinity based on coimmunoprecipi-
tation (Fig. 2C) or GST pull-down experiments (Fig. 3C). Iso-
thermal titration microcalorimetry measurements will have to
be performed to determine the Kd and the stoichiometry of the
interaction between eIF3g and Paip1 isoforms (45).
Silencing of various eIF3 subunits by siRNA blocked the
Paip1-dependent translation enhancement, demonstrating that
eIF3 is required for Paip1 activity (Fig. 7A). Paip1-eIF3 is
therefore likely to stabilize the interaction of eIF4G with
PABP (Kd of 20 nM) (26) and, consequently, the circular
mRNA configuration. Thus, Paip1 might act as a proxy
through which eIF3 mediates PABP stimulation of translation.
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